相关实验视频

Updated: May 20, 2025

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis
07:25

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis

Published on: May 4, 2017

17.7K

实施基于的间接比较方法,用于生物相似开发中的等价差额导出

Claudia Hemmelmann1, Rachid El Galta1, Jessie Wang2

  • 1Hexal AG, Industriestr. 25, D-83607 Holzkirchen, Germany.

Pharmaceuticals (Basel, Switzerland)
|March 27, 2025
PubMed
概括

本研究引入了基于的间接比较方法,用于在没有直接试验数据的情况下推导等效率 (EQM). 这种方法是可接受的卫生当局有强大的敏感性分析.

关键词:
生物相似性 生物相似性同等价值保证金的等价差额.间接方法是间接的方法.网络元分析 网络元分析

更多相关视频

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

4.9K
Generic Protocol for Optimization of Heterologous Protein Production Using Automated Microbioreactor Technology06:24

Generic Protocol for Optimization of Heterologous Protein Production Using Automated Microbioreactor Technology

Published on: December 15, 2017

9.9K

相关概念视频

Bioequivalence: Overview01:16

Bioequivalence: Overview

Pharmaceutical equivalents, by definition, are drug products with the same active ingredient in the same quantities, encapsulated in identical dosage forms, and intended for the same administration routes. These pharmaceutical equivalents are deemed bioequivalent if the bioavailability of the active entity in the drug preparations is similar. Moreover, pharmaceutical equivalents demonstrating bioequivalence are also regarded as therapeutically equivalent. This means that when used as directed,...
899